Prof. (Dr.) Manjari Tripathi — Neurologist, Epileptologist, Clinician-Scientist

Profile

Three decades at the point
where medicine meets the brain

Administrator, team leader, neurologist, epileptologist, clinician-scientist, educator and academic leader — with more than three decades of work in clinical neurology, epilepsy, sleep neurology, cognitive neurology, autoimmune neurology, translational research, medical education and national health policy.

MBBS at MKCG Medical College, Odisha, followed by MD at Victoria and DM in Neurology at NIMHANS, Bengaluru, in 1996. After faculty service at St. John's Medical College, Bengaluru, she joined AIIMS New Delhi as Assistant Professor in December 1998, and is now Professor and Head of the Department of Neurology, holding the Dr. S. Ramachandran Chair in Neurosciences.

Her postgraduate training was extended through a postdoctoral fellowship in epilepsy and clinical neurophysiology at UCLA under Prof. Jerome Engel, a concurrent rotation at the UCLA Sleep Disorders Center, and the Penry Mini-Fellowship at Wake Forest University School of Medicine.

Three contributions stand apart. She was senior and corresponding author on the first paper with an entirely Indian authorship published in The New England Journal of Medicine. She established the clinical use of magnetoencephalography in India and set out standards for presurgical epilepsy evaluation now followed nationally. And she led a Level 1 study of yoga as an intervention to reduce stigma in epilepsy.

FRCP (Edin) 2021 FNASc 2019 FNAMS 2023 FIAN 2022

Patient Service

Twenty-eight years of continuous clinical service at AIIMS. Clinical charge of 100 neurology beds at the Neurosciences Centre and six beds at the MEG Resource Facility. Conceived and built the Centre of Excellence for Epilepsy — a single-roof service uniting neurology, neurosurgery, neuroradiology, neuropathology, neuropsychology and counselling. Sub-specialty services in drug-resistant epilepsy, dementia, sleep medicine, autoimmune neurology and headache.

Education

Primary supervisor for 54 DM Neurology dissertations and 21 PhD scholars; more than 250 neurologists trained. Founded India's annual Basic and Advanced EEG and Polysomnography workshops. Visiting Professor at INI Hannover, Rabat and Surabaya; PhD examiner for Monash, Aarhus and Helsinki. Conducted the first ILAE Surgical Mentorship Programme, establishing an indigenous epilepsy-surgery service in Indonesia.

III

Research

591 publications, 526 PubMed-indexed; 27,333 citations; h-index 66; two patents. Senior and corresponding author of the first randomised controlled trial of epilepsy surgery in children, published in the New England Journal of Medicine. Randomised trials in Neurology on yoga for epilepsy stigma and on the Modified Atkins Diet. Principal Investigator on grants from DBT, DST, ICMR, DHR, the Principal Scientific Adviser, NIH and WHO.

Societal Contribution

Founder and mentor of the Ekatwam epilepsy patient-support group; awareness and screening camps in rural and underserved districts through IREACH; President of the Delhi chapter of the Alzheimer's and Related Disorders Society of India. Contributions to the National Essential Medicines List, the National MNS Operational Guidelines, Ayushman Bharat health-benefit packages, ICMR Standard Treatment Workflows and the CBSE School Health Manuals.

Administrative Capability

Head of the Department of Neurology since 2023; Head of Unit II and of the Centre of Excellence for Epilepsy from 2011. Principal Investigator of the MEG Resource Facility across three funding phases, including its transition to CSR support. Member of the Institute Body and Standing Finance Committee, AIIMS Rishikesh. Co-administers the National Task Force on Brain Health across twelve aspirational districts.

Research Contributions

Four enquiries, one method

Each line of work begins with a clinical question and moves from mechanism to diagnosis, to treatment and, ultimately, to public health and education. The work has appeared in The New England Journal of Medicine, The Lancet, JAMA Neurology, Neurology, the Journal of Neurology, Neurosurgery and Psychiatry, and Biological Psychiatry.

Confronting Drug-Resistant Epilepsy

Publications 1–325
Highest impact factor 84.5

"Why do so many people with epilepsy continue to have seizures despite the availability of modern anti-seizure medications?"

01 · Presurgical evaluation and protocol-building

Comprehensive presurgical evaluation protocols established at AIIMS and transferred across India — and internationally to Nepal, Indonesia, Kenya and Morocco. Work with multidisciplinary teams showed how neuroimaging, electrophysiology, electrocorticography, neuropathology and cognitive assessment combine to identify epileptogenic networks more accurately.

Success measured not only by seizure freedom, but by restored quality of life and reduced stigma.

02 · Magnetoencephalography and functional imaging

Led the first clinical application of MEG in India, evaluating it systematically alongside SPECT and other modalities. Prospective blinded studies demonstrated the additional diagnostic value of magnetic source imaging in presurgical localisation, improving confidence in surgical decision-making.

03 · Molecular and translational neuroscience

At the Prof. P. N. Tandon Neurobiology Laboratory, resected ictal-onset tissue from operated patients was studied to map the mechanisms of epileptogenesis — GABA receptor dysfunction, glutamate-mediated excitation, inflammatory pathways, epigenetic regulation, oxidative stress, lipidomics, proteomics, tryptophan–kynurenine metabolism, Wnt and fibronectin–integrin signalling, and focal cortical dysplasias.

04 · Affordable and accessible therapies

First to document the use of mobile-phone home videos in diagnosing epilepsy and distinguishing epileptic from functional dissociative seizures. Randomised controlled trial of the Modified Atkins Diet in adolescents and adults — to her group's knowledge the first trial of this dietary therapy in an adult population — published in Neurology, 2023. Also intranasal midazolam, mHealth-supported adherence and the pharmacoeconomics of anti-seizure medication.

05 · Artificial intelligence and network approaches

Research extending into AI, robotic stereoelectroencephalography, network analysis, minimally invasive epilepsy surgery and precision neuroimaging, supported by an ICMR grant — treating epilepsy not as a single lesion but as a disorder of interconnected brain networks.

06 · Public health, stigma and equity

Work on epilepsy-related stigma, depression, quality of life, women's health, cognitive outcomes, community awareness and equitable access — feeding directly into national treatment guidelines, educational initiatives and health policy.

A single continuing enquiry: from where seizures arise, to why, to better detection, better therapy, and systems of care that bring precision medicine within reach of every person living with epilepsy.

Building India's Dementia Evidence Base

Publications 326–413
Highest impact factor 54.6

"Can Alzheimer's disease be detected earlier and diagnosed more accurately in Indian patients — and can modern dementia care be made accessible to them?"

01 · The Indian face of dementia

Demographic, vascular, nutritional, metabolic and genetic risk factors of particular relevance to the Indian setting. Contributions to Lancet Neurology on dementia in developing countries documented the burden in low- and middle-income countries and argued that prevention and early diagnosis would become a leading health priority of the century.

02 · A national neurocognitive assessment framework

Joined the national effort to develop and validate the MUDRA–ICMR Neurocognitive Toolbox. Validated the Montreal Cognitive Assessment in five Indian languages, developed culturally appropriate picture-naming tests, and adapted the Addenbrooke's Cognitive Examination for illiterate populations — so cognitive impairment can be identified irrespective of a patient's language or literacy.

03 · Biological signatures

With the National Brain Research Centre, demonstrated that brain glutathione depletion occurs in the earliest stages of Alzheimer's disease — published in Biological Psychiatry, establishing oxidative stress as an early biological event and glutathione as an imaging biomarker detecting neurodegeneration before substantial neuronal loss.

04 · Decoding the biology of neurodegeneration

Candidate biomarkers including serum tau, phosphorylated tau, glutathione, Sestrin, Sirtuin-1, folate pathway alterations, inflammatory cytokines and APOE interactions. Metabolomics work has identified pathways not previously implicated, and examined how the gut microbiota influences neurodegeneration — a view of Alzheimer's as a systems disease.

05 · Lifestyle, networks and precision medicine

Non-pharmacological interventions — yoga, meditation, cognitive training, probiotics and caregiver support — with recorded gains in quality of life, cognition, brain network efficiency and gut microbiome composition. Using MEG, meditation was shown to enhance small-world brain network efficiency in attention and executive control systems.

06 · From evidence to national policy

The evidence generated has informed national dementia guidelines, neurocognitive assessment tools for national use, the Dementia India Report, disability evaluation frameworks, school health manuals, ICMR Standard Treatment Workflows, Ayushman Bharat health packages and national cognitive screening initiatives.

Towards Healthy Brain Ageing

Publications 414–443
Highest impact factor 84.5

"Sleep is not a passive interval between periods of waking but an active biological repair process — and one of the most powerful modifiable determinants of lifelong neurological and cardiovascular health."

01 · Establishing sleep as a determinant of brain health

Early work laid the foundations of sleep medicine in India through practical guidance on polysomnography and the assessment of insomnia, excessive daytime sleepiness, parasomnias and sleep disorders arising in neurological disease.

02 · Standardising measurement

The Childhood and Adolescent Sleep Evaluation Questionnaire (CASEQ), developed and validated by her group, is among the first validated ICSD-3-based screening instruments for children — giving clinicians and researchers a standardised tool for identifying sleep disorders in children and adolescents.

03 · Sleep across neurological disease

High prevalence of sleep abnormality demonstrated in children with drug-resistant epilepsy, establishing sleep assessment as integral to epilepsy management. Studies of sleep after stroke showed disturbance to be common, under-recognised and associated with poorer recovery — establishing sleep as a determinant of neurological outcome rather than an accompanying symptom.

04 · Sleep, cognition and healthy ageing

Population-based studies showed obstructive sleep apnoea and poor sleep quality are associated with impaired cognition in middle-aged and elderly adults, with poor sleep efficiency particularly affecting executive function and episodic memory — identifying sleep as a potentially modifiable risk factor for cognitive decline.

05 · Obstructive sleep apnoea as systemic disease

Her sleep laboratory was an international investigator site in the SAVE trial, published in the New England Journal of Medicine — the largest randomised trial of CPAP therapy in obstructive sleep apnoea, and one of the largest clinical evidence bases in the field.

06 · Translating sleep science into therapy

A randomised clinical trial demonstrated that Yoga Nidra significantly improves sleep in chronic insomnia — the first high-quality global evidence for this accessible non-pharmacological intervention. Electrophysiological studies further showed it induces measurable local sleep-like brain activity, offering a biological correlate of its therapeutic effect.

Mechanisms, Neuromodulation and Precision Care

Publications 493–503
Impact factor 8.9

"Can headache care move beyond the relief of symptoms to the identification of underlying biological mechanisms and the delivery of safer, evidence-based therapy?"

01 · Characterising the burden

Early clinical studies characterised migraine in Indian populations at a time when headache disorders were relatively under-recognised — establishing an epidemiological foundation that helped clinicians regard migraine as a common and disabling neurological illness rather than recurrent head pain.

02 · From description to mechanism

Studies of chronic tension-type headache examined the contribution of excessive temporalis muscle activity, demonstrating that persistent headache reflects an interaction between peripheral muscle activity and central pain-processing networks.

03 · Non-pharmacological therapies

The CONTAIN randomised clinical trial, published in Neurology, established yoga as an effective adjunctive therapy in migraine — supplying controlled clinical evidence for its incorporation into neurological care rather than treating it as an alternative practice.

04 · Neuromodulation

Pilot studies showed low-frequency repetitive transcranial magnetic stimulation could reduce pain and disability in chronic tension-type headache; a subsequent randomised controlled trial confirmed rTMS as a non-invasive treatment option for patients who continue to experience disabling headache despite conventional treatment.

Current Programmes as Principal Investigator

Centre of Excellence and MEG Resource Facility, Phase III — advanced neuroimaging integrating MEG with MRI, PET and EEG to localise epileptogenic networks. Now sustained on corporate social responsibility funding.
Non-coding RNAs in Focal Cortical Dysplasia (DBT) — RNA-Seq of resected brain tissue to refine FCD classification and inform targeted therapy.
Genomic and non-coding transcriptomic perturbances in pharmacoresistant epilepsy (DST) — copy number variations and non-coding RNAs, integrating genomic, transcriptomic, bioinformatic and functional validation approaches.
Dementia Science Programme (AADAR) (DBT) — a national multicentric programme on incidence, prevalence, risk and intervention in dementia across India.
NeuroSimulation-AI / MANAS (ICMR) — an individualised virtual brain model and machine-learning ecosystem for prediction of epilepsy localisation, with a real-time feedback mechanism.

Landmark Publications

Ten papers, chosen for range

Randomised trials, diagnostic method development, international consensus and global burden-of-disease collaboration. Impact factors range from 4.3 to 88.5. The complete list runs to 591 entries.

N Engl J Med
2017

Surgery for drug-resistant epilepsy in children

Dwivedi R, Ramanujam B, Chandra PS, … Tripathi M (corresponding author), … Sarkar C, Tripathi M. N Engl J Med 2017;377:1639–1647.

The first randomised controlled trial of surgery for drug-resistant epilepsy in children, and the first all-Indian-authored study published in the New England Journal of Medicine. Adding surgery to medical therapy produced a significantly higher proportion of seizure-free children at one year, establishing surgery as standard care — and demonstrating that trial evidence of this order can be generated in India.

84.5Impact factor

Lancet
2021

Measuring routine childhood vaccination coverage in 204 countries and territories, 1980–2019

GBD 2020 Release 1 Vaccine Coverage Collaborators. Lancet 2021 Aug 7;398(10299):503–521.

The highest-impact paper in this list. A Global Burden of Disease analysis across four decades and 204 countries, exposing stalled progress and the coverage losses of 2020 — evidence of participation in the large international consortia that generate the estimates on which national and global health policy is set.

88.5Impact factor

N Engl J Med
2016

CPAP for prevention of cardiovascular events in obstructive sleep apnoea — the SAVE trial

McEvoy RD, Antic NA, Heeley E, … Tripathi M, … Anderson CS; SAVE Investigators. N Engl J Med 2016 Sep 8;375(10):919–31.

The largest randomised trial of CPAP therapy in obstructive sleep apnoea, conducted in patients with established vascular disease. CPAP did not significantly reduce major cardiovascular events but did improve snoring, daytime sleepiness, mood and quality of life — resetting expectations of CPAP as a cardiovascular preventive therapy.

84.5Impact factor

Lancet Neurol
2026

Emerging technologies and strategies in epilepsy surgery: toward personalised medicine

Yardi R, Englot DJ, Wu C, Davis K, Baxendale S, Tripathi M, Jehi L. Lancet Neurol 2026 Jan;25(1):77–89.

An invited Lancet Neurology review setting out how advanced imaging, stereo-EEG, robotics, artificial intelligence and network analysis are moving epilepsy surgery towards personalised medicine — synthesising the evidence on precision localisation and individualised surgical planning, and outlining the field's research priorities.

54.6Impact factor

Lancet Neurol
2008

Alzheimer's disease and vascular dementia in developing countries: prevalence, management and risk factors

Kalaria RN, Maestre GE, Arizaga R, … Tripathi M, … Williams J. World Federation of Neurology Dementia Research Group. Lancet Neurol 2008;7(9):812–26.

A World Federation of Neurology review that drew early attention to the rising dementia burden in low- and middle-income nations, and remains a frequently cited reference for dementia epidemiology and policy in those settings.

54.6Impact factor

Lancet Public Health
2025

Global, regional and national burden of epilepsy, 1990–2021

GBD Epilepsy Collaborators. Lancet Public Health 2025 Mar;10(3):e203–e227.

A systematic analysis of epilepsy across three decades, quantifying prevalence, mortality and disability at global, regional and national level and documenting persistent inequities in low- and middle-income countries. It forms part of the evidence base used for epilepsy health policy and resource allocation.

26.5Impact factor

Neurology
2023

Effectiveness of yoga intervention in reducing felt stigma in adults with epilepsy: a randomised controlled trial

Kaur K, Sharma G, Dwivedi R, … Tripathi M. Neurology 2023 Dec 4;101(23):e2388–e2400.

A randomised controlled trial showing that a structured yoga intervention significantly reduced felt stigma in adults with epilepsy compared with a sham programme, with accompanying gains in quality of life and seizure-related outcomes — controlled evidence that a low-cost mind–body intervention can address the social stigma borne by people with epilepsy.

8.9Impact factor

Neurology
2023

Safety, efficacy and tolerability of the Modified Atkins Diet in persons with drug-resistant epilepsy: a randomised controlled trial

Manral M, Dwivedi R, Gulati S, … Tripathi M. Neurology 2023 Mar 28;100(13):e1376–e1385.

A randomised controlled trial showing that the Modified Atkins Diet, added to standard therapy, is safe, well tolerated and significantly reduces seizures in adolescents and adults with drug-resistant epilepsy — rigorous evidence for an affordable dietary therapy in a population for which such data were scarce.

8.9Impact factor

Epilepsia
2014

Diagnostic test utilisation evaluation for resective epilepsy surgery in children

Jaykar P, Gaillard WD, Tripathi M, Libenson MH, Mathern GW, Cross JH; ILAE Task Force for Epilepsy Surgery. Epilepsia 2014;55(4):507–18.

An International League Against Epilepsy Task Force consensus standardising how diagnostic tests should be used when evaluating children for epilepsy surgery — a reference framework used by paediatric epilepsy-surgery programmes internationally.

6.6Impact factor

Eur J Neurol
2021

Diagnostic added value of interictal magnetic source imaging in presurgical evaluation: a prospective blinded study

Tripathi M, Kaur K, Ramanujam B, … Chandra PS. Eur J Neurol 2021 Sep;28(9):2940–2951.

A prospective, blinded study establishing the added diagnostic value of MEG-based magnetic source imaging in presurgical evaluation, showing it yields non-redundant localising information that alters surgical decision-making — drawing on India's first clinical magnetoencephalography facility, which she leads.

4.3Impact factor

PubMed Google Scholar ResearchGate IRINS Profile

Institutional Leadership

What was built, what it cost,
and what it now delivers

Set out in terms of responsibility carried, systems built and resources raised, rather than titles held.

The Centre of Excellence for Epilepsy

An institution within the institution

The Centre did not exist when she began. She conceived it, secured its funding, and built it into a single-roof, multidisciplinary service in which neurologists, neurosurgeons, neuroradiologists, neuropathologists, neuropsychologists, dieticians and counsellors work around one patient.

Within it she established India's first clinical magnetoencephalography service, initiated under the SAHAJ scheme of the Department of Biotechnology, and carried it through three successive funding phases — Phases I and II under DBT grant support, and Phase III on corporate social responsibility funding after the grant cycle closed.

"Sustaining a national facility beyond the life of its founding grant required identifying a corporate partner, negotiating the terms, and satisfying both institutional and donor governance. It is the same problem an institution faces at a larger scale."

Exported, not retained

Presurgical evaluation and epilepsy-management protocols developed at the Centre have been transferred to sister AIIMS institutions, NIMHANS, the Neurofoundation Hospital at Salem and SMS Medical College Jaipur — and to centres in Nepal, Indonesia, Morocco and Israel.

100Neurology beds
under clinical charge

3Funding phases
sustained

2011Head of Unit II &
Centre of Excellence

2023Head of Department
of Neurology

Present scope of responsibility

Department of Neurology, AIIMS New Delhi — clinical, academic and administrative charge
Neurology inpatient services, Neurosciences Centre — 100 beds
MEG Resource Facility, NBRC Manesar — 6 beds; PI across all funding phases
National Task Force on Brain Health — co-administers the pilot across 12 aspirational districts
Disability Assessment in Neurology, AIIMS — Chairperson

Governance and Financial Responsibility

Member, Institute Body, AIIMS Rishikesh — the apex governing body of an AIIMS
Member, Standing Finance Committee, AIIMS Rishikesh — budgetary and financial scrutiny at institute level
Secretary General, Indian Epilepsy Society
President, Delhi Chapter, Alzheimer's and Related Disorders Society of India
Member, PhD Committee, NIMHANS, Bengaluru
Editorial Board, Epilepsia; committees and task forces of the ILAE and IBE
Executive Committee — Indian Academy of Neurology; Indian Society for Sleep Research; Indian Sleep Disorders Association

Systems Built and Reformed

Digitised neurophysiology reporting. EEG, video-EEG and polysomnography reports are now generated and retrieved directly at the OPD terminal, removing a paper hand-off that delayed clinical decisions.
Strengthened laboratory capacity. Neurophysiology staffing expanded and structured, SOP-based hands-on training introduced at every level, competency assessment made routine.
Continuity of service. Rostering reorganised to secure uninterrupted staffing and round-the-clock consultant availability.

Resource Mobilisation

Research and infrastructure funding secured and administered as Principal Investigator from DBT, DST, ICMR, DHR, the Office of the Principal Scientific Adviser, the United States NIH, the WHO, international university consortia (Auckland, Monash) and corporate social responsibility partners.

Teaching and Mentorship

Building people

Primary supervisor for 54 DM Neurology dissertations and 21 PhD scholars, and mentor to more than 250 neurologists and neuroscientists — teaching across MBBS, DM, PhD, nursing and allied-health cadres since 1998.

Orations and International Teaching

Orations, keynote lectures, grand rounds and invited presentations at UCLA, the Cleveland Clinic, the Montreal Neurological Institute, Northwestern University and Rush University, as well as institutions in Egypt and Morocco. Visiting Professor in Germany, Indonesia, Sri Lanka, Nepal and Morocco.

She established India's annual Basic and Advanced EEG and Polysomnography Workshops and continues to lead national epilepsy schools and advanced neuroscience training programmes. PhD examiner for Monash, Aarhus and Helsinki.

INI Hannover Rabat Surabaya

The ILAE Surgical Mentorship Programme · Indonesia, 2024

She conducted the first ILAE Surgical Mentorship Programme, jointly with Prof. P. Sarat Chandra, to develop epilepsy-surgery capability in Indonesia — a country of more than 270 million people which until then had no dedicated epilepsy-surgery centre. It was hosted by Dr Soetomo General Academic Hospital, Surabaya.

A four-week online phase attended by over 100 participants, with structured teaching and multidisciplinary case reviews alongside the ILAE Surgical Commission
Thirteen candidates worked up; eight finalised for surgery
An on-site fortnight in May 2024 — case conferences, a public-awareness seminar, a full-day symposium for ~80 specialists, and hands-on workshops
Five operations performed with the local team, including temporal lobectomy with amygdalohippocampectomy, stereotactic lesioning of a hypothalamic hamartoma, electrocorticography-guided resection with motor mapping, and vagus-nerve-stimulator implantation
Monthly online case reviews instituted between Surabaya, Salem, Jaipur and AIIMS New Delhi — establishing an indigenous and enduring service rather than a single event

Honours, Awards and Distinctions

Recognition

2025

Certificate of Honour — "Women in Medicine 2025"

National Academy of Medical Sciences (India), at NAMSCON-2025, PGIMER Chandigarh

2025
–27

Dr. S. Ramachandran Chair in Neurosciences

All India Institute of Medical Sciences, New Delhi

2025

4th AIIMS Annual Research Day — Third Prize, Excellence in Clinical Sciences

All India Institute of Medical Sciences, New Delhi

2023

Fellow of the National Academy of Medical Sciences, India (FNAMS)

National Academy of Medical Sciences (India)

2022

Fellow of the Indian Academy of Neurology (FIAN)

Indian Academy of Neurology

2021

Fellow of the Royal College of Physicians of Edinburgh (FRCP Edin)

Royal College of Physicians of Edinburgh

2019

Fellow of the National Academy of Sciences, India (FNASc)

National Academy of Sciences, India

2019

Achievement and Academic Excellence Award in Sleep Medicine in India

American Association of Physicians of Indian Origin — Sleep (AAPIOS), San Antonio, Texas

2019

Guru Dronacharya Award in Neurology

Omnicuris, CME Excellence Summit and Awards 2019

2018

AIIMS Excellence Research Award — First Prize, Clinical Research

All India Institute of Medical Sciences, New Delhi

2018

BMJ Best Research Paper Award

BMJ

2016

Outstanding Achievement Award in Epilepsy

For extraordinary contribution to epilepsy — 11th Asian & Oceanian Epilepsy Congress, Hong Kong (ILAE / IBE)

2013

Outstanding Faculty in Research Award

All India Institute of Medical Sciences, New Delhi

2012

Anandibai Joshi Award for Medicine

Integrated Rural Development Society

2012

Chief of the Army Staff Award

Armed Forces Medical College, Pune

1991

Gold Medallist in MBBS

Anatomy, Physiology and Medicine — Berhampur University

Career and Training

The path

Positions

2023 — present

Professor and Head, Department of Neurology

AIIMS New Delhi. Clinical, academic and administrative charge. Professor since 2011.

2011 — 2023

Head, Unit II and Centre of Excellence for Epilepsy

With administrative charge of the MEG Resource Facility, NBRC Manesar.

2007 — 2011

Additional Professor, Department of Neurology

AIIMS New Delhi.

2003 — 2007

Associate Professor, Department of Neurology

AIIMS New Delhi.

1998 — 2003

Assistant Professor, Department of Neurology

AIIMS New Delhi. Joined December 1998.

1997 — 1998

Lecturer, then Assistant Professor, Neurology

St. John's Medical College, Bengaluru.

1991 — 1997

Junior and Senior Residency, Neurology

NIMHANS, Bengaluru — a six-year integrated programme, the first two years in general medicine at Victoria and Bowring Hospitals.

Education and Advanced Training

2008

Mini-Fellowship Program for International Scholars

American Academy of Sleep Medicine.

2006

Penry Epilepsy Mini-Fellowship

Wake Forest University School of Medicine.

2005 — 06

Postdoctoral Fellowship, Epilepsy and Clinical Neurophysiology

University of California, Los Angeles — faculty sponsor Prof. Jerome Engel. With a concurrent sleep rotation at the UCLA Sleep Disorders Center, David Geffen School of Medicine.

2005 — 06

Principles and Practice of Clinical Research

National Institutes of Health Clinical Center.

1996

DM, Neurology

National Institute of Mental Health and Neurosciences, Bengaluru.

1993

MD Part I, General Medicine

Victoria and Bowring Hospitals, Bengaluru — within the NIMHANS integrated programme.

1991

MBBS — Gold Medallist

MKCG Medical College, Berhampur University, Odisha. Gold medals in Anatomy, Physiology and Medicine.

Prof. (Dr.)Manjari Tripathi

Three decades at the pointwhere medicine meets the brain

Patient Service

Education

Research

Societal Contribution

Administrative Capability

Four enquiries, one method

Confronting Drug-Resistant Epilepsy

01 · Presurgical evaluation and protocol-building

02 · Magnetoencephalography and functional imaging

03 · Molecular and translational neuroscience

04 · Affordable and accessible therapies

05 · Artificial intelligence and network approaches

06 · Public health, stigma and equity

Building India's Dementia Evidence Base

01 · The Indian face of dementia

02 · A national neurocognitive assessment framework

03 · Biological signatures

04 · Decoding the biology of neurodegeneration

05 · Lifestyle, networks and precision medicine

06 · From evidence to national policy

Towards Healthy Brain Ageing

01 · Establishing sleep as a determinant of brain health

02 · Standardising measurement

03 · Sleep across neurological disease

04 · Sleep, cognition and healthy ageing

05 · Obstructive sleep apnoea as systemic disease

06 · Translating sleep science into therapy

Mechanisms, Neuromodulation and Precision Care

01 · Characterising the burden

02 · From description to mechanism

03 · Non-pharmacological therapies

04 · Neuromodulation

Ten papers, chosen for range

Surgery for drug-resistant epilepsy in children

Measuring routine childhood vaccination coverage in 204 countries and territories, 1980–2019

CPAP for prevention of cardiovascular events in obstructive sleep apnoea — the SAVE trial

Emerging technologies and strategies in epilepsy surgery: toward personalised medicine

Alzheimer's disease and vascular dementia in developing countries: prevalence, management and risk factors

Global, regional and national burden of epilepsy, 1990–2021

Effectiveness of yoga intervention in reducing felt stigma in adults with epilepsy: a randomised controlled trial

Safety, efficacy and tolerability of the Modified Atkins Diet in persons with drug-resistant epilepsy: a randomised controlled trial

Diagnostic test utilisation evaluation for resective epilepsy surgery in children

Diagnostic added value of interictal magnetic source imaging in presurgical evaluation: a prospective blinded study

What was built, what it cost,and what it now delivers

An institution within the institution

Building people

Writing what is learned at AIIMSinto instruments that govern practice

Recognition

Certificate of Honour — "Women in Medicine 2025"

Dr. S. Ramachandran Chair in Neurosciences

4th AIIMS Annual Research Day — Third Prize, Excellence in Clinical Sciences

Fellow of the National Academy of Medical Sciences, India (FNAMS)

Fellow of the Indian Academy of Neurology (FIAN)

Fellow of the Royal College of Physicians of Edinburgh (FRCP Edin)

Fellow of the National Academy of Sciences, India (FNASc)

Achievement and Academic Excellence Award in Sleep Medicine in India

Guru Dronacharya Award in Neurology

AIIMS Excellence Research Award — First Prize, Clinical Research

BMJ Best Research Paper Award

Outstanding Achievement Award in Epilepsy

Outstanding Faculty in Research Award

Anandibai Joshi Award for Medicine

Chief of the Army Staff Award

Gold Medallist in MBBS

The path

Professor and Head, Department of Neurology

Head, Unit II and Centre of Excellence for Epilepsy

Additional Professor, Department of Neurology

Associate Professor, Department of Neurology

Assistant Professor, Department of Neurology

Lecturer, then Assistant Professor, Neurology

Junior and Senior Residency, Neurology

Mini-Fellowship Program for International Scholars

Penry Epilepsy Mini-Fellowship

Postdoctoral Fellowship, Epilepsy and Clinical Neurophysiology

Principles and Practice of Clinical Research

DM, Neurology

MD Part I, General Medicine

Three decades at the point
where medicine meets the brain

What was built, what it cost,
and what it now delivers

Writing what is learned at AIIMS
into instruments that govern practice